Yahoo
HKSE - Delayed Quote HKD

VISEN Pharmaceuticals (2561.HK)

14.630 +0.700 (+5.03%)
As of 9:45:55 AM GMT+8. Market Open.
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
34,707
165
0
0
0
Cost of Revenue
16,626
146
0
--
--
Gross Profit
18,081
19
0
--
--
Operating Expense
240,536
240,563
174,178
138,830
358,286
Operating Income
-222,455
-240,544
-174,178
-138,830
-358,286
Net Non Operating Interest Income Expense
8,315
10,679
6,609
10,828
4,948
Pretax Income
-239,505
-253,422
-182,242
-249,570
-288,967
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-239,505
-253,422
-182,242
-249,570
-288,967
Diluted NI Available to Com Stockholders
-239,505
-253,422
-182,242
-249,570
-288,967
Basic EPS
-2.21
-2.44
-1.76
-2.67
-3.09
Diluted EPS
-2.21
-2.44
-1.76
-2.67
-3.09
Basic Average Shares
108,254.385
103,667.937
103,536.364
93,636.364
93,636.364
Diluted Average Shares
108,254.385
103,667.937
103,536.364
93,636.364
93,636.364
Rent Expense Supplemental
--
--
467
344
316
Total Expenses
257,162
240,709
174,178
138,830
358,286
Net Income from Continuing & Discontinued Operation
-239,505
-253,422
-182,242
-249,570
-288,967
Normalized Income
-239,504
-243,867
-164,877
-123,769
-274,563
Interest Income
11,406
11,777
6,770
11,145
5,567
Interest Expense
3,091
1,098
161
317
619
Net Interest Income
8,315
10,679
6,609
10,828
4,948
EBIT
-236,414
-252,324
-182,081
-249,253
-288,348
EBITDA
-232,817
-249,159
-177,615
-242,257
-280,951
Reconciled Cost of Revenue
16,626
146
0
--
--
Reconciled Depreciation
3,597
3,165
4,466
6,996
7,397
Net Income from Continuing Operation Net Minority Interest
-239,505
-253,422
-182,242
-249,570
-288,967
Total Unusual Items Excluding Goodwill
-1
-9,555
-17,365
-125,801
-14,404
Total Unusual Items
-1
-9,555
-17,365
-125,801
-14,404
Normalized EBITDA
-232,816
-239,604
-160,250
-116,456
-266,547
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 3/21/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: